Inventor · disambiguated record
Christian Buchholz
Also filed as: BUCHHOLZ CHRISTIAN
8 granted patents·9 pending applications·35 citations·filing 2001–2023
83Inventor score
Files withBUCHHOLZ CHRISTIAN3LUSCH GMBH & CO KG FERD3ECOLE NORMALE SUPERIEURE LYON2BIOFOCUS DISCOVERY LTD1BIONTECH CELL & GENE THERAPIES GMBH1
Top patents by PatentIndex Score
17 records- 0186US11608509B2Nipah virus envelope glycoprotein pseudotyped lentivirusECOLE NORMALE SUPERIEURE LYON·Filed 2017·Granted Mar 21, 2023·6 cites·10 claims
- 0272US7823966B2Recliner chairLUSCH GMBH & CO KG FERD·Filed 2007·Granted Nov 2, 2010·14 cites·9 claims
- 0371US10415057B2Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screeningBundesrepublik Deutschland letztvertreten durch·Filed 2017·Granted Sep 17, 2019·3 cites·6 claims
- 0470US6387686B2Methods and compositions for identifying a polynucleotide encoding a proteaseBIOFOCUS DISCOVERY LTD·Filed 2001·Granted May 14, 2002·6 cites·51 claims
- 0568US9862971B2Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screeningBUCHHOLZ CHRISTIAN·Filed 2007·Granted Jan 9, 2018·3 cites·18 claims
- 0667US2023348934A1Methods for selectively modulating the activity of distinct subtypes of cellsECOLE NORMALE SUPERIEURE LYON·Filed 2023·Application pending·0 cites
- 0760US9683397B2Pivot fitting for pieces of furniture for sitting and/or lying onLUSCH GMBH & CO KG FERD·Filed 2014·Granted Jun 20, 2017·3 cites·15 claims
- 0859US2025101071A1Binding proteins specific for cd32aPAUL EHRLICH INST BUNDESINST FUER IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL·Filed 2023·Application pending·0 cites
- 0952US2024207402A1Means and methods for enhancing receptor-targeted gene transferDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2022·Application pending·0 cites
- 1047US12018273B2CD62L specific lentiviral vector particle for targeted transduction of T cell subsetsMILTENYI BIOTEC BV & CO KG·Filed 2021·Granted Jun 25, 2024·0 cites·14 claims
- 1144US2023049655A1In vitro and in vivo gene delivery to immune effector cells using nanoparticles functionalized with designed ankyrin repeat proteins (darpins)BIONTECH CELL & GENE THERAPIES GMBH·Filed 2020·Application pending·0 cites
- 1243US2010322956A1Methods and substances for the treatment of alzheimer'sMUELLER ULRIKE·Filed 2008·Application pending·0 cites
- 1341US9901179B2Piece of seating furniture having a pivotable functional partLUSCH GMBH & CO KG FERD·Filed 2015·Granted Feb 27, 2018·0 cites·14 claims
- 1434US2018161395A1Methods and pharmaceutical composition for the treatment of alzheimer's diseaseINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 1530US2015291979A1Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cellsPAUL EHRLICH INST FED OFFICE FOR SERA AND VACCINE·Filed 2013·Application pending·0 cites
- 1629US2014065694A1Enhanced tumor therapy by tumor stem cell targeted oncolytic virusesBUCHHOLZ CHRISTIAN·Filed 2012·Application pending·0 cites
- 1725US2014018521A1Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scFv)BUCHHOLZ CHRISTIAN·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christian Buchholz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →